187 related articles for article (PubMed ID: 35450934)
21. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
22. The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment Characteristics of Operated Lung Cancer Patients.
Arak H; Eronat O; Dogan I; Aydin ES; Aytekin A
J Coll Physicians Surg Pak; 2023 Nov; 33(11):1271-1277. PubMed ID: 37926880
[TBL] [Abstract][Full Text] [Related]
23. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
24. The impact of Covid-19 on patients with suspected cancer: An analysis of ED presentation and referrals to a quick diagnosis unit.
Bosch X; Capdevila A; Grafia I; Ladino A; Moreno PJ; López-Soto A
Am J Emerg Med; 2021 Oct; 48():1-11. PubMed ID: 33836386
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Survival of Combined Hepatocellular-Cholangiocarcinoma: A Nationwide Study.
Chen PD; Chen LJ; Chang YJ; Chang YJ
Oncologist; 2021 Oct; 26(10):e1774-e1785. PubMed ID: 34213048
[TBL] [Abstract][Full Text] [Related]
26. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
Pais R; Fartoux L; Goumard C; Scatton O; Wendum D; Rosmorduc O; Ratziu V
Aliment Pharmacol Ther; 2017 Nov; 46(9):856-863. PubMed ID: 28857208
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Massarweh NN; El-Serag HB
Cancer Control; 2017; 24(3):1073274817729245. PubMed ID: 28975830
[TBL] [Abstract][Full Text] [Related]
28. Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic.
Janczewski LM; Browner AE; Cotler JH; Palis BE; Chan K; Joung RH; Bentrem DJ; Merkow RP; Boffa DJ; Nelson H
JAMA Netw Open; 2024 Mar; 7(3):e240160. PubMed ID: 38441896
[TBL] [Abstract][Full Text] [Related]
29. Impact of the COVID-19 pandemic on liver transplant waitlist outcome in France.
Legeai C; Antoine C; Jasseron C; Kerbaul F; Dumortier J
Sci Rep; 2023 Jun; 13(1):9308. PubMed ID: 37291177
[TBL] [Abstract][Full Text] [Related]
30. [Impact of COVID-19 pandemic in liver transplantation in Argentina. Other collateral damage].
Gondolesi GE; Reyes-Toso ML; Bisigniano L; de Santibañes M; Pekolj J; Maurette R; Quiñonez EG; Maraschio MA; Imventarza O; Lendoire J; Bitetti L; Ruf A; Aballay G; Gil O; Mattera FJ; Barros Schelotto P; Descalzi VI
Medicina (B Aires); 2020; 80 Suppl 6():71-82. PubMed ID: 33481736
[TBL] [Abstract][Full Text] [Related]
31. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team.
Dyson J; Jaques B; Chattopadyhay D; Lochan R; Graham J; Das D; Aslam T; Patanwala I; Gaggar S; Cole M; Sumpter K; Stewart S; Rose J; Hudson M; Manas D; Reeves HL
J Hepatol; 2014 Jan; 60(1):110-7. PubMed ID: 23978719
[TBL] [Abstract][Full Text] [Related]
33. Obesity and liver cancer.
Saitta C; Pollicino T; Raimondo G
Ann Hepatol; 2019; 18(6):810-815. PubMed ID: 31543467
[TBL] [Abstract][Full Text] [Related]
34. Assessing the impact of COVID-19 on liver cancer management (CERO-19).
Muñoz-Martínez S; Sapena V; Forner A; Nault JC; Sapisochin G; Rimassa L; Sangro B; Bruix J; Sanduzzi-Zamparelli M; Hołówko W; El Kassas M; Mocan T; Bouattour M; Merle P; Hoogwater FJH; Alqahtani SA; Reeves HL; Pinato DJ; Giorgakis E; Meyer T; Villadsen GE; Wege H; Salati M; Mínguez B; Di Costanzo GG; Roderburg C; Tacke F; Varela M; Galle PR; Alvares-da-Silva MR; Trojan J; Bridgewater J; Cabibbo G; Toso C; Lachenmayer A; Casadei-Gardini A; Toyoda H; Lüdde T; Villani R; Matilla Peña AM; Guedes Leal CR; Ronzoni M; Delgado M; Perelló C; Pascual S; Lledó JL; Argemi J; Basu B; da Fonseca L; Acevedo J; Siebenhüner AR; Braconi C; Meyers BM; Granito A; Sala M; Rodríguez-Lope C; Blaise L; Romero-Gómez M; Piñero F; Gomez D; Mello V; Pinheiro Alves RC; França A; Branco F; Brandi G; Pereira G; Coll S; Guarino M; Benítez C; Anders MM; Bandi JC; Vergara M; Calvo M; Peck-Radosavljevic M; García-Juárez I; Cardinale V; Lozano M; Gambato M; Okolicsanyi S; Morales-Arraez D; Elvevi A; Muñoz AE; Lué A; Iavarone M; Reig M
JHEP Rep; 2021 Jun; 3(3):100260. PubMed ID: 33644725
[TBL] [Abstract][Full Text] [Related]
35. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.
Sapisochin G; de Lope CR; Gastaca M; de Urbina JO; López-Andujar R; Palacios F; Ramos E; Fabregat J; Castroagudín JF; Varo E; Pons JA; Parrilla P; González-Diéguez ML; Rodriguez M; Otero A; Vazquez MA; Zozaya G; Herrero JI; Antolin GS; Perez B; Ciria R; Rufian S; Fundora Y; Ferron JA; Guiberteau A; Blanco G; Varona MA; Barrera MA; Suarez MA; Santoyo J; Bruix J; Charco R
Ann Surg; 2014 May; 259(5):944-52. PubMed ID: 24441817
[TBL] [Abstract][Full Text] [Related]
36. Impact of the COVID-19 pandemic on non-small-cell lung cancer pathologic stage and presentation.
Keogh JAJ; Chhor AD; Begum H; Akhtar-Danesh N; Finley C
Can J Surg; 2022; 65(4):E496-E503. PubMed ID: 35926883
[TBL] [Abstract][Full Text] [Related]
37. Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis.
Tovoli F; Guerra P; Iavarone M; Veronese L; Renzulli M; De Lorenzo S; Benevento F; Brandi G; Stefanini F; Piscaglia F
Liver Cancer; 2020 Dec; 9(6):744-755. PubMed ID: 33442543
[TBL] [Abstract][Full Text] [Related]
38. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.
Mehta N; Parikh ND; Kelley RK; Hameed B; Singal AG
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1520-1530. PubMed ID: 32652308
[TBL] [Abstract][Full Text] [Related]
39. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
Hassan I; Gane E
Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
[TBL] [Abstract][Full Text] [Related]
40. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
